Macrocure
Priced, Nasdaq: MCURIsraeli biotech developing white blood cell injections to treat hard-to-heal wounds.
Industry: Health Care
First Day Return: -27.5%
MCUR
Israeli biotech developing white blood cell injections to treat hard-to-heal wounds.
| IPO Date | 07/30/2014 |
|---|---|
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $54 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| IPO Intelligence Only |
| Headquarters | Petach Tikva, Israel |
|---|---|
| Founded | 2008 |
| Employees at IPO | 26 |
| Website www.macrocure.com | |
IPO News for Macrocure
Macrocure (MCUR) Performance
